Skip to main content

Table 2 FDG and RGD uptake in Hodgkin and non-Hodgkin patients before (C0) and after (C2) chemotherapy

From: Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence

FDG C0 C2
Hodgkin Non-Hodgkin p-value Hodgkin Non-Hodgkin p-value
n = 6 n = 13 n = 6 n = 10
SUVmax ± SD 14.8 ± 4.7 17.0 ± 8.6 0.56 2.6 ± 1.3 5.1 ± 2.0 0.02
MTV ± SD 91.8 ± 60 254 ± 306 0.22 33 ± 65 27.6 ± 40.6 0.4
RGD n = 6 n = 13   n = 5 n = 7  
SUVmax ± SD 3.9 ± 1.4 1.9 ± 1.1 0.002 3.1 ± 1.1 3.6 ± 1.8 0.6
ATV ± SD 145 ± 125 3.2 ± 9  < 0.001 46 ± 45 45 ± 99 0.9